Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid-Reference-Cited by-同舟云学术

Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid

Published:2016-04-01 Issue:6 Volume:81 Page:1113-1123
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

van Hasselt J. G. Coen¹,Rizk Matthew L.²,Lala Mallika²,Chavez-Eng Cynthia²,Visser Sandra A. G.²,Kerbusch Thomas³,Danhof Meindert¹,Rao Gauri⁴,van der Graaf Piet H.¹

Affiliation:

1. Division of Pharmacology, Cluster Systems Pharmacology, Leiden Academic Centre for Drug Research; Leiden University; Leiden The Netherlands

2. Merck & Co. Inc.; Kenilworth New Jersey USA

3. Quantitative Solutions BV; Oss The Netherlands

4. University at Buffalo; Buffalo New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12901/fullpdf

Reference46 articles.

1. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy;Clissold;Drugs,1987

2. Pharmacokinetics of imipenem in healthy volunteers;Norrby;J Antimicrob Chemother,1983

3. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers;Norrby;Antimicrob Agents Chemother,1984

4. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation;Lee;Diagn Microbiol Infect Dis,2010

5. Prospective determination of plasma imipenem concentrations in critically ill children;Giannoni;Antimicrob Agents Chemother,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamic modeling of colistin and imipenem againstin vitro Pseudomonas aeruginosabiofilms;2024-06-02

2. Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics;Antimicrobial Agents and Chemotherapy;2024-02-07

3. Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis;Heliyon;2023-10

4. Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis;Open Forum Infectious Diseases;2023-05-04

5. Cefepime, not Piperacillin/Tazobactam use, for empirical treatment of bloodstream infections caused by Enterobacter spp.: Results from a population pharmacokinetic/pharmacodynamic analysis;European Journal of Pharmaceutical Sciences;2023-01